Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYSZ2400041	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	License Renew	2024-07-06	Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie	view
JYSZ2400040	度普利尤单抗注射液	dupilumab	Injection	Biological Products(3.1)	License Renew	2024-07-06	Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie	view
JYSB2500079	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-25	Sanofi Winthrop Industrie	view
JYSB2500078	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-25	Sanofi Winthrop Industrie	view
JYSB2500077	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-25	Sanofi Winthrop Industrie	view
JYSB2500076	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-25	Sanofi Winthrop Industrie	view
JYSB2500069	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-19	Sanofi Winthrop Industrie	view
JYSB2500068	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2025-03-19	Sanofi Winthrop Industrie	view
JYSB2400111	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17	Sanofi Winthrop Industrie	view
JYSB2400110	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17	Sanofi Winthrop Industrie	view
JYSB2400109	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17	Sanofi Winthrop Industrie	view
JYSB2400108	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-05-17	Sanofi Winthrop Industrie	view
JYSB2400077	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-04-04	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2400076	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2024-04-04	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2300135	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2023-08-15	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2300134	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2023-08-15	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2200208	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-10-22	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2200207	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-10-22	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2200175	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-09-09	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view
JYSB2200174	度普利尤单抗注射液	dupilumab	Injection	Biological Products	Supplementary Application	2022-09-09	Sanofi-Aventis Groupe;Sanofi Winthrop Industrie	view